[1]
“De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery”, J. Can. Res. Updates, vol. 15, no. 3, pp. 249–261, Aug. 2026, doi: 10.30683/1929-2279.2026.15.23.